Skip to content
Open access

Metabolic Abnormalities Among Youths Receiving Antipsychotics Across Different Exposure Periods

Oct 2026 · JAMA Network Open · Vol 9, pp. e2639615 · 0 citations · 9 references
Medicine

Abstract

This population-based self-controlled case series study evaluates the risk of metabolic abnormalities across various exposure time intervals following antipsychotic initiation in children and adolescents in Hong Kong.

Read PDF

Similar papers

Open access Oct 2026

Epilepsy-Related Mortality Among Children and Adolescents

This cross-sectional study assesses temporal trends in epilepsy-related mortality from 1999 to 2023 among individuals aged 0 to 19 years in the US.

Naum Shaparin, Rafi Khandaker, Jan-Niklas Schwarz et al. · 0 citations
Open access Oct 2026

Implementing pharmacogenomics for LAI antipsychotics

Differences among individuals in drug exposure and response are well‐known variables for practicing clinicians. Over the last few decades, investigators have begun to present evidence for how pharmacogenetic strategies might optimize treatment for patients based on their genetic determinants of drug efficacy and toxici...

Y. W. Francis Lam · 0 citations
Oct 2026

Dementia Risk Symptoms and Function in Adults with Down syndrome

Date presented: April 25, 2026 Primary Author and Speaker: Selena Washington, selena.washington@health.slu.edu

Selena E. Washington, A. Bodde, B. Helsel et al. · 0 citations
Open access Oct 2026

Early Adoption and Diffusion of Oral Semaglutide in US Adults With Obesity

This cohort study evaluates early treatment trends of oral semaglutide among adults eligible for obesity management medications following its approval for obesity.

Yu-Qing Lei, Hui-Lin Tang, Xin-Yao Jian et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.